These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9115580)

  • 1. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
    Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
    J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
    Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
    J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study.
    Myung SJ; Yang SK; Jung HY; Chang HS; Park B; Hong WS; Kim JH; Min I
    Int J Colorectal Dis; 2002 Jul; 17(4):233-7. PubMed ID: 12073071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
    Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
    Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
    World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
    Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
    Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis.
    Masuda H; Nakamura Y; Tanaka T; Hayakawa S
    Am J Gastroenterol; 1994 Nov; 89(11):1957-62. PubMed ID: 7942717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
    García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
    Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China.
    Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A
    J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
    Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and immunological markers in pouchitis.
    Brett PM; Yasuda N; Yiannakou JY; Herbst F; Ellis HJ; Vaughan R; Nicholls RJ; Ciclitira PJ
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):951-5. PubMed ID: 8930557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
    Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP
    Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA class-II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
    Lee YT; Sung JJ; Poon P; Lai KN; Li PK
    Scand J Gastroenterol; 1998 Jun; 33(6):623-7. PubMed ID: 9669635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup.
    Duerr RH; Neigut DA
    Gastroenterology; 1995 Feb; 108(2):423-7. PubMed ID: 7835583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAP gene transporter polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Bretagne JF; Dabadie A; Colombel JF; Pagenault M; Heresbach-Le Berre N; Genetet B; Gosselin M; Semana G
    Scand J Gastroenterol; 1997 Oct; 32(10):1022-7. PubMed ID: 9361175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey.
    Uyar FA; Imeryüz N; Saruhan-Direskeneli G; Ceken H; Ozdoğan O; Sahin S; Tözün N
    Eur J Immunogenet; 1998 Aug; 25(4):293-6. PubMed ID: 9777329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Ruiz-Morales JA; Higuera L; Cutiño T; Rodríguez-Pérez JM; Villarreal-Garza C; Granados J
    Hum Immunol; 2003 Jan; 64(1):119-23. PubMed ID: 12507822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese.
    Seki SS; Sugimura K; Ota M; Matsuzawa J; Katsuyama Y; Ishizuka K; Mochizuki T; Suzuki K; Yoneyama O; Mizuki N; Honma T; Inoko H; Asakura H
    Tissue Antigens; 2001 Aug; 58(2):71-6. PubMed ID: 11696218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.